Monday, November 09, 2009
Criminal off-label drug promotion
Bloomberg story here. Wonder how the present First Amendment challenge to the off-label marketing rules will affect the ability to prosecute such acts?
Labels:
fda
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment